Hoffmann-La Roche Inc licensee Hormone Research Foundation patent synthetic version human growth hormone enter license agreement Eli Lilly Co involve Lilly's Humatrope hormone treat dwarfism children. Details license agreement disclose company official unavailable comment. A statement company "Lilly Roche enter license agreement alternative litigation." South San Francisco-based Genetech Inc GENE> market genetically engineer human growth hormone call Protropin. Lilly receive approval Food Drug Administration market human growth hormone earlier year. A Lilly spokesperson company effect license patent hormone Hoffman-LaRoche. She refuse comment term license agreement. Last September Hoffman-LaRoche Foundation sue Genetech Federal court California allege product infringe Hoffman's patent synthetic hormone. Reuter 